Ipsogen's French IVD Shop Wins ISO Certification | GenomeWeb
NEW YORK (GenomeWeb News) — Ipsogen said today it has received ISO 13485 certification covering the manufacture and sale of in vitro diagnostic medical devices at its headquarters in Marseille, France.
 
The certification covers Ipsogen’s blood-based IVDs for molecular analysis, diagnosis, prognosis, and follow-ups in cancer patients.
 
Ipsogen CEO Vincent Fert said the certification shows “compliance with a significant part of the FDA Quality System Regulation."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.